Dynamic immune-inflammation-nutrition biomarkers and outcomes in advanced non-small cell lung cancer treated with immunotherapy

Coverage, in order

1. 4h ago
   Research Square obscure study

   Dynamic immune-inflammation-nutrition biomarkers and outcomes in advanced non-small cell lung cancer treated with immunotherapy

   Purpose While immune checkpoint inhibitors (ICIs) have improved survival in advanced non-small cell lung cancer (NSCLC), therapeutic benefits vary and current biomarkers are often costly or static. This study evaluated the associations of baseline and dynamic immune-inflammation-nutrition (IIN)…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.